Search

everythinglearnresearchcommunity

for

Search:↓

Eclipta alba extract may help treat obesity by blocking fat cell formation and lowering blood lipid levels.

Certain microRNAs are linked to various skin diseases and could be used to diagnose and treat these conditions.

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

Loss of a specific protein in skin cells causes symptoms similar to psoriasis.

Brazilian patients with inflammatory bowel disease have a high rate of skin problems compared to healthy people.

The document concludes that better biomarkers are needed to detect long-term oral testosterone use in athletes.

The Foxn1 gene mutation causes hairlessness and immune system issues, and understanding it could lead to hair growth disorder treatments.

Current research explores hair growth drugs, while future research aims for personalized treatments.

Transverse scalp biopsies are more accurate for diagnosing non-cicatricial alopecia, but examining both types is best for accuracy.

A group has developed therapies that show promise for treating cancer and various other conditions.

Keratinocytes help heal skin wounds by interacting with immune cells and producing substances that kill pathogens.

Combining cyclosporine A and ketoconazole can effectively treat anal furunculosis in dogs, with some experiencing recurrences and mild side effects.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

FOXN1 gene variants cause low T cells and immune issues from birth.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Keratosis pilaris is often linked to genetic mutations and causes skin and hair abnormalities, regardless of those mutations.

Topical vitamin D3 does not prevent hair loss from chemotherapy.

Horizontally sectioned scalp biopsies are more reliable for diagnosing hair loss in women when three samples are taken instead of one.

The guidelines suggest using various treatments, including antidepressants and steroids, for alopecia areata and discuss the condition's genetic and immune aspects.

UVA1-light therapy successfully treated a child's skin condition, mycosis fungoides.

Alopecia areata involves immune response and gene changes affecting hair loss.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

The document concludes that more research is needed to understand and treat Beard Alopecia Areata due to limited current knowledge and evidence.

The document explains various skin conditions and their treatments.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.